Stephen Richard - 14 Jun 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ Stephen Richard
Issuer symbol
ANIK
Transactions as of
14 Jun 2023
Transactions value $
$0
Form type
4
Filing time
16 Jun 2023, 16:16:52 UTC
Previous filing
10 Jun 2022
Next filing
11 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Award $0 +6,500 +30.32% $0 27,936 14 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024.